ABSTRACT
of HLA-DR from mature DCs, the expression of CD80 and CD86 co-activation molecules, the production of IL-12p70 required for antigen presentation and Th1 differentiation, and inhibited the DC-induced T cell proliferation. These modulations were mediated by CD19 + IgD low CD38 + CD24 low CD27 -B cells and needed direct cell-tocell contacts that involved CD62L for the control of CD80 and CD86 expression, and a soluble factor for the control of IL-12 production. Moreover, mature DCs from systemic lupus erythematosus patients displayed insensitivity to the regulation of IL-
12.
Overall, it appears that human B cells can regulate DC maturation and function and that inefficient B-cell regulation may influence an improper balance between an effector inflammatory response and tolerance induction. co-stimulatory molecules, and production of T-cell activating cytokines, such as interleukin (IL)-12, to trigger differentiation of T cells into efficient Th1 effector cells. 2 To acquire these characteristics, DC precursors differentiate into immature and then to mature DCs 3 as a result of activation mediated by granulocyte macrophagecolony stimulating factor (GM-CSF) and IL-4, and by Toll-like receptor (TLR) activating products such as lipopolysaccharides (LPS). However, the functional properties of DCs vary depending on the stage of maturation. Thus, mature DCs (mDCs) stimulate T-cell immunity, whereas immature DCs (iDCs) favor T-cell tolerance rather than immunity. 4 Furthermore, autoimmune diseases such as systemic lupus erythematosus (SLE) might result from break in peripheral tolerance due to activation of DCs. 5 If so, the control of the maturation and function of DCs should provide important tools to modulate aberrant autoimmune and inflammatory responses. 6, 7 For personal use only. on August 31, 2017. by guest www.bloodjournal.org From -4 -B cells were first recognized as immune cells committed to antibody (Ab) production, i.e., defined as effector cells of the humoral immune response. However, numerous studies have since revealed that B cells are regulators of immunity. 8 They have the ability to synthesize cytokines, 9 to act as APCs for T cells, 10 and to govern the architecture of secondary lymphoid organs by encouraging development of DCs. 11 Moreover, murine models of autoimmune and inflammatory diseases have suggested that B cells may also regulate pathological processes. Following the release of one or several mediators and/or direct cell-to-cell contacts, B cells can modulate DC functions and consequently immune responses. Thus, in lupus mice, autoreactive B cells contribute to the severity of the disorder once activated through their TLR9, but exert also a negative role on DC function if they secrete considerable amount of IL-10. 12 In the µMT mouse model of arthritis, B cells are lacking and hence, DCs produce high quantities of pro-inflammatory IL-12p70 and do not secrete IL-4 compared with wild-type mice. This DC-mediated exacerbation of the inflammatory response is caused by the absence of IL-10 high secreting B cells. 13 The contact with the B cells to induce their own B cell-dependent regulation. 18 In addition, we distinguished control of T cell proliferation from control of the Th1 differentiation.
T cell differentiation depended on IL-10 production and CD86 interactions, whereas proliferation depended on CD40 interactions and did not require any soluble factor.
Interestingly, this regulation was defective in human SLE. In this study, we asked the question as to whether human DCs can be controlled by B lymphocytes, and evaluated the efficiency of the B cell regulation in autoimmunity. We have demonstrated that, upon activation by CD40L and CpG-oligodeoxynucleotides (ODN), human B cells inhibited the maturation and function of DCs. They modulated the maturation of monocytes into iDCs and slowed down their differentiation into mDCs. They also reduced the expression of HLA-DR, CD80 and CD86 co-activation molecules, and the production of IL-12p70 from mDCs. The DC-induced T cell proliferation was therefore restrained. Cell-to-cell contacts without provision of soluble factors were sufficient to regulate the expression of cell surface molecules. Among them was
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From -6 -CD62L which participated into the regulation of CD80 and CD86, whilst cell-to-cell contacts in association with an unidentified soluble factor regulated the production of IL-12. Our data suggest that human B cells can be potent regulators of inflammation induced by DCs. In addition, mDCs from SLE patients were refractory to the regulation of IL-12p70 by either SLE or control B cells suggesting that the lack of Bcell regulation in SLE may be due to inefficient response of mDCs. The insensitivity of mDCs to these regulatory B cells may influence the balance between effector inflammatory responses and tolerance induction in SLE and may contribute to the pathogenesis of this autoimmune disorder. 
METHODS

Isolation of cells
Peripheral blood from normal controls was donated by healthy laboratory staff members. Blood samples from patients with SLE and rheumatoid arthritis (RA) were collected after obtaining informed consent in accordance with the Declaration of Helsinki. Ethical approval was given by the Institutional Review Board of the Brest University Hospital. All patients fulfilled the criteria for the respective diseases. 19, 20 Tonsils were minced up and filtered to remove tissue fragments and clumps. Blood 
Co-culture assays
Monocytes were purified and seeded at 4. 
Flow cytometry
All mAbs were purchased from Bekman-Coulter, unless otherwise specified. We used 
Statistical analysis
Statistical analyses were performed with Prism 4 Graphpad software. Comparisons were performed using the Wilcoxon's test for paired data. p<0.05 was considered as significant.
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RESULTS
B cells regulate DC maturation
To obtain mDCs, purified monocytes were stimulated with GM-CSF and IL-4 to We first asked whether B cells had a potential effect on the maturation process, i.e., at precursors level to retard monocyte differentiation into iDCs and then, at iDCs level, to prevent their complete maturation into mDCs. When monocytes were stimulated in the presence of activated tonsillar B cells, their differentiation into iDCs was contained since the GM-CSF and IL-4-dependent upregulation of the markers was lower ( Figure   1A ). Thus, the MFI of HLA-DR, CD80 and CD86 were significantly diminished (p<0.05) on day 6 ( Figure 1B ). The whole monocyte population was also affected as seen by CD40, CD45RO, CD58 and CD11b expression that decreased homogeneously leading to a unique population of dimly positive cells ( Figure 1C ). However, reduction of CD54 and CD11c expression was observed, but not on all iDCs. Furthermore, the expression of CD25 and CD83 was increased, implying that regulatory effects were specific. These results suggest that human B cells have a regulatory influence over monocytes to prevent their optimal differentiation into iDCs. Differentiated iDCs were then stimulated at day 6 with LPS and IFN-γ in the presence of activated B cells for another 2 days. Expression of HLA-DR decreased on the whole iDC population, and subpopulations of CD80 low and CD86 low iDCs appeared, whereas the production of IL-12p70 was unaffected ( Figure 1D ). Thus, B cells generated a unique population of iDCs with significantly less HLA-DR expression (p<0.05), and also high numbers of cells (p<0.05) that weakly expressed CD80 and CD86 ( Figure   1E ). Singularly, CD45RO was downregulated on all iDCs, and the B cell regulation on CD11b and CD11c was restricted to a subpopulation of iDCs, whilst CD83 expression 
B cell regulation requires cell-to-cell contacts
Co-activation of CD40 and TLR9 on B cells induced IL-10 secretion (1073.9 ± 815.6 µg/mL) that has been suspected to play a key regulatory role in several models. 12, 13, 17, 18 Furthermore, IL-10 has been identified as a key cytokine to control the phenotype of monocytes 21,22 and of iDCs. 23 We have therefore sought ways to measure the importance of IL-10 in the regulatory effect of human B cells on mDCs. Figure 3D ). These data indicate that TGF-β is not the B cellderived cytokine that regulates the production of IL-12p70 by mDCs in our model.
The phenotype of the regulatory B cells
We then asked the question as to whether non-stimulated B cells could possess intrinsic regulatory capacities. In the presence of freshly-isolated B cells, a decrease in the MFI of HLA-DR was not observed, whereas the populations of CD80 low (p<0.01), CD86 low (p<0.02) and IL12p70 low (p<0.01) mDCs were slightly increased ( Figure 4A ).
Furthermore, activated B cells induced stronger regulatory effects that were statistically more important on the 3 mDC functions than those with the non- The expression of cell-interaction molecules and those involved in cellular adhesion were also measured ( Figure 4C ). Non-stimulated B cells were CD40 + and remained so after CD40L/CpG-ODN activation. In co-culture, CD40 density increased on B cells.
Since DCs can express CD40L, 24 CD40 appeared to be a viable candidate as having a role in the regulatory process. mDCs and activated B cells were cultured in the presence of anti-CD40L-blocking Ab ( Figure 5A ). Their regulatory effect on HLA-DR, CD80, CD86 and IL-12p70 expressions still persisted (p<0.05) and was not statistically modified. It is therefore unlikely that CD40-CD40L interactions had a role in the regulatory effects of B cells in our model. 
B cell regulation in autoimmune diseases
Having It is now evident that DCs are not only considered as APCs that initiate primary immune responses, but are also involved in tolerance induction. 26 However, there is almost no evidence that a specific subset of DCs determine immunity or tolerance.
27
These properties may be the consequence of activation status 28 and more likely might depend on their maturation status. 4 Due to diminished expression of co-stimulatory molecules, iDCs favor the induction of peripheral T-cell tolerance 23 
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-24 -appear to be efficient stimulators of T-cell immune response due to the elevated expression of HLA-DR, CD80, CD86 and production of cytokines. Consequently, through their capacity to inhibit the maturation of DCs, we assume that B cells can operate as inhibitors of T-cell immunity and as instigators of DC-based tolerance induction. Importantly, DCs can contribute to the development of autoimmunity. Thus, when they are deleted in lupus mice, the disease is ameliorated. 29 In contrast, systemic autoimmunity occurs when they cannot be eliminated in normal mice. Characteristic of the intercellular contact involved in regulation.
Monocytes were purified from the peripheral blood of healthy donors and stimulated with GM-CSF (1000 U/mL) and IL-4 (500 U/mL) for 6
days. The differentiated immature DCs, were stimulated with LPS (100 ng/mL) and IFN-γ (1000 U/mL) for 24h to generate mature DCs. from RA patients were activated as above and added with their supernatant to autologous DCs. MFI of HLA-DR (6 and 8 samples for SLE and RA patients, respectively), percentages of CD80 low (8 and 10 samples for SLE and RA patients, respectively), CD86 low (6 and 10 samples for SLE and RA patients, respectively) and IL-12 low (7 and 10 samples for SLE and RA patients, respectively) DCs were evaluated by flow cytometry on CD19-negative cells. Activated tonsillar B cells were used as controls (Ctrl). *p<0.05; **p<0.01; ns, non significant. 
